Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03073343 · ClinicalTrials.gov registry record · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
A NA study of Non-alcoholic Fatty Liver Disease and Non Insulin Dependent Diabetes, sponsored by Southern California Institute for Research and Education.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT03073343 is a NA study of Non-alcoholic Fatty Liver Disease and Non Insulin Dependent Diabetes that is actively recruiting participants, run by Southern California Institute for Research and Education. The registered enrollment target is 48 participants, below the 189-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03073343, a NA study of Non-alcoholic Fatty Liver Disease and Non Insulin Dependent Diabetes, is actively recruiting participants, sponsored by Southern California Institute for Research and Education.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
Betaine (trimethyglycine) is a food supplement that is approved for sale in the United States without a prescription. In this study, betaine will be provided to patients as a powder that can be mixed with aqueous solutions and consumed orally.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Betaine (trimethyglycine)
Study Locations (1)
California
- VA Long Beach Healthcare System - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2013-11-12 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03073343
The ClinicalTrials.gov registry entry for NCT03073343 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 189-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (75% lower). The listed sponsor is Southern California Institute for Research and Education, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which Betaine (trimethyglycine) is the first listed.
NCT03073343 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03073343 about?
NCT03073343 is a clinical study titled "A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine". Betaine (trimethyglycine) is a food supplement that is approved for sale in the United States without a prescription. In this study, betaine will be provided to patients as a powder that can be mixed with aqueous solutions and consumed orally.
What is the current status of trial NCT03073343?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2013-11-12. Estimated completion is 2025-12-30.
What conditions does trial NCT03073343 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease, Non Insulin Dependent Diabetes, ALT.
What interventions are being tested in trial NCT03073343?
The interventions under investigation include: Betaine (trimethyglycine) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03073343?
This trial is sponsored by Southern California Institute for Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03073343 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
The Olmsted NAFLD Epidemiology Study (TONES)
RECRUITING · NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
RECRUITING · NA
-
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
ACTIVE NOT RECRUITING · NA
-
Prevention of NAFLD in Hispanic Children
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Non-alcoholic Fatty Liver Disease
All registered trials for this condition
Non Insulin Dependent Diabetes
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.